MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2016 International Congress

June 19-23, 2016. Berlin, Germany.

View by Title View Sessions
View by Date

Thursday, June 23, 2016

12:00pm-1:30pm
Long-latency somatosensory evoked potentials of the subthalamic nucleus

C. Trenado, S. Elben, L. Friggemann, S. Gruhn, S. Groiss, J. Vesper, A. Schnitzler, L. Wojtecki (Düsseldorf, Germany)

Other  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Long-term comparative outcomes of functional neurosurgical procedures for treatment of secondary hemidystonia

W.O. Contreras Lopez, A.R.C. Azevedo, M.G. Guilardi, M. San Martin Sepulveda, R.C.R. Martinez, M.J. Teixeira, E.T. Fonoff (São Paulo, Brazil)

Dystonia  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Long-term effects of a short inpatient rehabilitation course and peer support in dystonia

K. Martikainen, S. Kinos, R. Marttila (Turku, Finland)

Dystonia  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Long-term effects of levodopa/carbidopa intestinal gel infusion in advanced Parkinson’s disease patients: Dutch multicenter retrospective cohort study

H.R. Moes, J. Groenendal-Laurensse, M. Drent, G. Tissingh, T. van Laar (Groningen, Netherlands)

Neuropharmacology  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Long-term effects of pallidal DBS in patients with primary dystonia

P. Krause, S. Völzmann, A. Kupsch, G.H. Schneider, A. Kühn (Berlin, Germany)

Dystonia  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Long-term results of pallidal deep brain stimulation in a cohort of eight children with isolated dystonia assessed by blinded video rating

P. Krause, K. Lauritsch, A. Lipp, A. Horn, B. Weschke, A. Kupsch, K. Kiening, G.H. Schneider, A. Kühn (Berlin, Germany)

Pediatric movement disorder  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Long-term safety of levodopa-carbidopa intestinal gel from an ongoing, open-label, phase 3 continued access to treatment study in advanced Parkinson’s disease patients

R.L. Rodriguez, C. Zadikoff, A.J. Espay, V.S.C. Fung, C. Hall, W.Z. Robieson, K. Chatamra, S. Eaton, M.F. Facheris, J. Benesh (Orlando, FL, USA)

Pharmacology
12:00pm-1:30pm
Loss of heart rate variability in ALS: Time and frequency domain assessment

P. Congiu, G. Milioli, G. Borghero, G. Gioi, F. Marrosu, M. Puligheddu, A.L. Goldberger, S. Mariani (Monserratoo, Italy)

Other  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Lovastatin protects neurite degeneration in LRRK2-G2019S parkinsonism through activating the Akt/Nrf pathway and inhibiting GSK3beta activity

C.H. Lin, H.I. Lin, M.L. Chen, T.T. Lai, L.P. Cao, M.J. Farrer, R.M. Wu, C.T. Chien (Taipei, Taiwan)

Pharmacology
12:00pm-1:30pm
LSVT-BIG© case studies: A snapshot of observations

L.A. Dearle (Johannesburg, South Africa)

Clinical trials and therapy in movement disorders  ·  Exhibit Hall located in Hall B, Level 2
  • «Previous Page
  • 1
  • …
  • 28
  • 29
  • 30
  • 31
  • 32
  • …
  • 53
  • Next Page»

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley